» Articles » PMID: 34489876

The Sputum Microbiome in Pulmonary Tuberculosis and Its Association With Disease Manifestations: A Cross-Sectional Study

Abstract

Each day, approximately 27,000 people become ill with tuberculosis (TB), and 4,000 die from this disease. Pulmonary TB is the main clinical form of TB, and affects the lungs with a considerably heterogeneous manifestation among patients. Immunomodulation by an interplay of host-, environment-, and pathogen-associated factors partially explains such heterogeneity. Microbial communities residing in the host's airways have immunomodulatory effects, but it is unclear if the inter-individual variability of these microbial communities is associated with the heterogeneity of pulmonary TB. Here, we investigated this possibility by characterizing the microbial composition in the sputum of 334 TB patients from Tanzania, and by assessing its association with three aspects of disease manifestations: sputum mycobacterial load, severe clinical findings, and chest x-ray (CXR) findings. Compositional data analysis of taxonomic profiles based on 16S-rRNA gene amplicon sequencing and on whole metagenome shotgun sequencing, and graph-based inference of microbial associations revealed that the airway microbiome of TB patients was shaped by inverse relationships between and two anaerobes: and . Specifically, the strength of these microbial associations was negatively correlated with Faith's phylogenetic diversity (PD) and with the accumulation of transient genera. Furthermore, low body mass index (BMI) determined the association between abnormal CXRs and community diversity and composition. These associations were mediated by increased abundance of and , relative to the abundance of , in underweight patients with lung parenchymal infiltrates and in comparison to those with normal chest x-rays. And last, the detection of herpesviruses and anelloviruses in sputum microbial assemblage was linked to co-infection with HIV. Given the anaerobic metabolism of and , and the hypoxic environment of lung infiltrates, our results suggest that in underweight TB patients, lung tissue remodeling toward anaerobic conditions favors the growth of and at the expense of . These new insights into the interplay among particular members of the airway microbiome, BMI, and lung parenchymal lesions in TB patients, add a new dimension to the long-known association between low BMI and pulmonary TB. Our results also drive attention to the airways virome in the context of HIV-TB coinfection.

Citing Articles

Effect of hyperglycemia on lung microbiota and treatment outcome in pulmonary tuberculosis: A scoping review.

Musyoki V, Mureithi M, Heikinheimo A, Maleche-Obimbo E, Kithinji D, Musau S F1000Res. 2025; 13:1543.

PMID: 39981106 PMC: 11840297. DOI: 10.12688/f1000research.159555.1.


Diagnosis and insight into the unique lung microbiota of pediatric pulmonary tuberculosis patients by bronchoalveolar lavage using metagenomic next-generation sequencing.

Zhou H, Pei Y, Xie Q, Nie W, Liu X, Xia H Front Cell Infect Microbiol. 2025; 14:1492881.

PMID: 39748884 PMC: 11693512. DOI: 10.3389/fcimb.2024.1492881.


Subtracting the background by reducing cell-free DNA's confounding effects on Mycobacterium tuberculosis quantitation and the sputum microbiome.

Naidoo C, Venter R, Codony F, Agusti G, Kitchin N, Naidoo S Sci Rep. 2024; 14(1):22350.

PMID: 39333362 PMC: 11436789. DOI: 10.1038/s41598-024-73497-3.


Airway microbiome signature accurately discriminates infection status.

Kayongo A, Ntayi M, Olweny G, Kyalo E, Ndawula J, Ssengooba W iScience. 2024; 27(6):110142.

PMID: 38904070 PMC: 11187240. DOI: 10.1016/j.isci.2024.110142.


The human lung microbiome-A hidden link between microbes and human health and diseases.

Yi X, Gao J, Wang Z Imeta. 2024; 1(3):e33.

PMID: 38868714 PMC: 10989958. DOI: 10.1002/imt2.33.


References
1.
Lin P, Flynn J . The End of the Binary Era: Revisiting the Spectrum of Tuberculosis. J Immunol. 2018; 201(9):2541-2548. PMC: 6217958. DOI: 10.4049/jimmunol.1800993. View

2.
Hong B, Maulen N, Adami A, Granados H, Balcells M, Cervantes J . Microbiome Changes during Tuberculosis and Antituberculous Therapy. Clin Microbiol Rev. 2016; 29(4):915-26. PMC: 5010754. DOI: 10.1128/CMR.00096-15. View

3.
Wejse C, Gustafson P, Nielsen J, Gomes V, Aaby P, Andersen P . TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis. 2007; 40(2):111-20. DOI: 10.1080/00365540701558698. View

4.
Steiner A, Hella J, Gruninger S, Mhalu G, Mhimbira F, Cercamondi C . Managing research and surveillance projects in real-time with a novel open-source eManagement tool designed for under-resourced countries. J Am Med Inform Assoc. 2016; 23(5):916-23. DOI: 10.1093/jamia/ocv185. View

5.
Thom K, Petrik J . Progression towards AIDS leads to increased Torque teno virus and Torque teno minivirus titers in tissues of HIV infected individuals. J Med Virol. 2006; 79(1):1-7. DOI: 10.1002/jmv.20756. View